These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27764814)

  • 1. Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis.
    Moon A; Do SI; Kim HS; Kim YW
    Oncotarget; 2016 Nov; 7(48):79319-79326. PubMed ID: 27764814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.
    Kim HS; Yoon G; Do SI; Kim SJ; Kim YW
    Oncotarget; 2016 Mar; 7(12):15187-99. PubMed ID: 26942563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.
    Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Cancer Sci; 2011 Feb; 102(2):472-7. PubMed ID: 21175991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
    Kim HS; Park SJ; Lee KY; Park YK; Kim YW
    Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
    Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
    Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
    Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
    Wang L; Lin D; Fu Y; Lai M
    Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
    Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
    Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection.
    Nanashima A; Yamaguchi H; Sawai T; Yasutake T; Tsuji T; Jibiki M; Yamaguchi E; Nakagoe T; Ayabe H
    J Gastroenterol Hepatol; 1999 Oct; 14(10):1004-9. PubMed ID: 10530497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
    Zhong A; Tian Y; Zhang H; Lai M
    J Surg Oncol; 2018 Apr; 117(5):1029-1037. PubMed ID: 29529342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.
    Han SA; Chun H; Park CM; Kang SJ; Kim SH; Sohn D; Yun SH; Lee WY
    Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):761-7. PubMed ID: 17168211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
    Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer.
    Tian B; Zhang Y; Li N
    Cancer Biother Radiopharm; 2013; 28(6):466-70. PubMed ID: 23745687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
    Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
    Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
    Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
    Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.